LDR, NuVasive stock prices jump following M&A news: 4 points

On June 7, LDR stock price jumped 64 percent to $37.03, and NuVasive stock also spiked to an all-time high of $59.71, according to an Investor’s Business Daily report.

Advertisement

Here are four points:

 

1. Both the stock price jumps come on the heels of major acquisition news regarding the two companies.

 

2. Zimmer Biomet announced its acquisition of LDR for $1 billion Tuesday. The acquisition helps Zimmer Biomet establish a global spine market footprint, especially in the cervical disc replacement and minimally invasive surgery segments.

 

3. NuVasive entered into a definitive agreement to acquire Biotronic NeuroNetwork for $98 million in cash Monday. Biotronic is a provider of intraoperative neurophysiological monitoring services.

 

4. M&A activity in the medical device market is ramping up with Medtronic announcing its acquisition of Responsive Orthopedics, a start-up focusing on knee and hip devices, on June 8.

 

More articles on devices:
Stryker’s SurgiCount Safety Sponges used in 10M procedure: 5 things to know
Ronda Stryker sells 12k company shares: 4 points
NuVasive to acquire Biotronic for $98M: 6 things to know

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.